Pharmabiz8m
UK MHRA grants marketing authorization to sparsentan to treat adult patients with primary immunoglobulin A nephropathy
UK MHRA grants marketing authorization to sparsentan to treat adult patients with primary immunoglobulin A nephropathy: United Kingdom Wednesday, November 20, 2024, 14:00 Hrs [IST ...
Pharmabiz38m
Indegene expands global delivery network, announces a new centre in Hyderabad
Indegene expands global delivery network, announces a new centre in Hyderabad: Our Bureau, Bengaluru Wednesday, November 20, 2024, 13:30 Hrs [IST] Indegene, a digital-first life s ...
Pharmabiz1h
Late-breaking data reinforce long-term benefits of Abbott's Amplatzer Amulet device for people with atrial fibrillation at risk of stroke
Abbott Park, Illinois Wednesday, November 20, 2024, 13:00 Hrs [IST] ...
Pharmabiz1h
India‘s medical tourism accounts for 8% global market share as international patients convinced on quality care and expertise
India‘s medical tourism accounts for 8% global market share as international patients convinced on quality care and expertise: Our Bureau, Bengaluru Wednesday, November 20, 2024 ...
Pharmabiz1h
Tata Elxsi, DENSO and AAtek set-up ‘Robotics and Automation Innovation Lab’ in Frankfurt
Tata Elxsi, DENSO and AAtek set-up ‘Robotics and Automation Innovation Lab’ in Frankfurt: Our Bureau, Bengaluru Wednesday, November 20, 2024, 12:50 Hrs [IST] Tata Elxsi, a glo ...
Pharmabiz2h
Biosion inks exclusive, global license pact with Aclaris Therapeutics on two potential first-in-class and best-in-class immunology assets
Biosion inks exclusive, global license pact with Aclaris Therapeutics on two potential first-in-class and best-in-class immunology assets: Newark, Delaware Wednesday, November 20, ...
Pharmabiz1h
HCG partners with Trucan Diagnostics for treatment response prediction and monitoring in cancer patients
HCG partners with Trucan Diagnostics for treatment response prediction and monitoring in cancer patients: Our Bureau, Bengaluru Wednesday, November 20, 2024, 12:40 Hrs [IST] Healt ...
Pharmabiz2h
AVPN & Bayer Foundation unveil US$ 5 million “Climate x Health: Lighthouse for Asia” Fund to protect community health
AVPN & Bayer Foundation unveil US$ 5 million “Climate x Health: Lighthouse for Asia” Fund to protect community health: Our Bureau, Bengaluru Wednesday, November 20, 2024, 11:1 ...
Pharmabiz3h
Telangana govt states it emerges as global life sciences hub with over Rs. 36,000 crore in investments, creating 51,000 jobs
Telangana govt states it emerges as global life sciences hub with over Rs. 36,000 crore in investments, creating 51,000 jobs: Our Bureau, Bengaluru Wednesday, November 20, 2024, 1 ...
Pharmabiz4h
GSK announces positive results from GLISTEN phase III trial of linerixibat in adults with cholestatic pruritus (relentless itch) associated with PBC
GSK announces positive results from GLISTEN phase III trial of linerixibat in adults with cholestatic pruritus (relentless itch) associated with PBC: London, UK Wednesday, Novembe ...
Pharmabiz3h
Endo expands voluntary recall of clonazepam orally disintegrating tablets, USP due to potential product carton strength mislabelling
Malvern, Pennsylvania Wednesday, November 20, 2024, 11:00 Hrs [IST] ...
Pharmabiz5h
16th Asia Pharma Expo 2025 & Asia Lab Expo 2025 to be at the BBCFEC, Purbachal, Dhaka from February 12-14, 2025
The 16th Asia Pharma Expo 2025 & Asia Lab Expo 2025, the region’s premier international pharmaceutical trade platform, will take place at the BBCFEC, Purbachal, Dhaka from February 12-14, 2025. This ...